Historical record - last NADAC effective date: 7/23/2014
Product Information
DOXYCYCLINE MONO 150 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $4.7305 per EA under NDC 63304017330. Its NADAC has been published 35 times since Nov 28, 2013.
FDA first approved this application on May 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304017330
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/23/2014
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA065356FDA Approved
5/31/2006
TE Code
AB
On Market Since
8/6/2018
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE MONO 150 MG TABLET has been published 35 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.7305 per EA |
|---|---|
| All-time high | $6.8363 (Feb 12, 2014) |
| All-time low | $4.7305 (Jul 23, 2014) |
| Median price | $5.2083 |
| Average price | $5.2636 |
| Largest weekly change | +43.5% (Jan 22, 2014) |
| Weeks tracked | 35 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-0.7%
Last surveyed Aug 13, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXYCYCLINE MONO 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 150 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $4.7305 per EA (NDC 63304017330), effective Aug 13, 2014.
How has the price of DOXYCYCLINE MONO 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has held within roughly two percent of its current level. It has been tracked across 35 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 150 MG TABLET?
Since Nov 28, 2013, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has ranged from a low of $4.7305 (Jul 23, 2014) to a high of $6.8363 (Feb 12, 2014), with a median of $5.2083 per EA.
Are there cheaper alternatives to DOXYCYCLINE MONO 150 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXYCYCLINE MONO 150 MG TABLET, is $0.6449 per EA — about 86% below DOXYCYCLINE MONO 150 MG TABLET.
Who manufactures DOXYCYCLINE MONO 150 MG TABLET?
DOXYCYCLINE MONO 150 MG TABLET (NDC 63304017330) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.